OCEANIC-AF
Multicenter, randomized, active comparator-controlled, double-blind, double-dummy, parallel group phase III study of the oral FXIa inhibitor BAY 2433334 for the prevention of stroke or systemic embolism in patients with atrial fibrillation
- Stadium
- klaar
- Middel
- FXIa inhibitor BAY 2433334
- Populatie
- Ritme
- Fase
- III
- First Patient In
- 16 januari 2023
- Last Patient In
- 20 november 2023
- Last Patient Last Visit
- 15 december 2023
National Lead
dr. M.E.W. Hemels
Cardioloog
Contact Kantoor
